Comparison of effects of midazolam and combined midazolam and dexamethasone for preventing emergence agitation in children undergoing strabismus surgery

Comparison of the effects of midazolam alone and a combination of midazolam and dexamethasone on the prevention of emergence agitation in pediatric patients undergoing strabismus surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011504

Enrollment

Registered

2026-01-21

Start date

2025-12-16

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : At induction of anesthesia, after administration of thiopental 4-5mg/kg and remifentanil 0.1ug/kg/min, patients in the midazolam group receive midazolam 0.05 mg/kg, whereas those in the midazol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: i) Children aged 2–8 years undergoing strabismus surgery under general anesthesia. ii) American Society of Anesthesiologists physical status classification I–II

Exclusion criteria

Exclusion criteria: i) Children with severe systemic disease classified as American Society of Anesthesiologists physical status III or higher. ii) Children whose legal guardians do not consent to the procedure. ?iii) Children with a history of hypersensitivity to the study drugs. ?iv) Children with psychiatric disorders or developmental disabilities. ?v) Children with a history of pediatric diabetes or those currently receiving treatment for diabetes.

Design outcomes

Primary

Measure	Time frame
the degree of emergence agitation	—

Secondary

Measure	Time frame
Postoperative nausea and vomiting	—

Countries

Korea, Republic of

Contacts

Public Contacteun kyung choe

Yeongnam University Medical Center

zzini0527@naver.com+82-53-620-3361

Outcome results